Cached score snapshot

US.ELV · Elevance Health

110分制 58.8/110;5D動能v2 17/50;排序分 75.8/160 · Incomplete inputs

Ranking score 75.8/160
Main score 58.8/110
5D momentum v2 17/50
Rank #5
Setup grade D 39

Score breakdown

觀望

Medium twelvedata

Score and price trend

D 39 Technical S · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-16 07-21 08-21 09-24 10-22 $352.18$430.48$508.77 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.297 · anchors 120 +0.40% -1.52% / +1.87% 58.8% 3.8% Actual outcome pending · 0 / 3 bars observed
30D observation +6.36% +0.08% / +12.53% 75% 11.3% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 +0.46% -1.49% / +2.71% 60.6% 3.1% Actual outcome pending · 0 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-06-16 → 2026-10-22 · 90 archived points · 1 Improving turn signal · 6 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 75.8
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 58.8/110 (觀望)
5D momentum v2 17/50 (弱)
Score with momentum v2 75.8/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Incomplete score

此 snapshot 已計出評分,但以下輸入仍不完整;缺失維度以 0 分處理,請留意 audit 明细。

  • VIX_MISSING: VIX market context is required for market environment scoring

Market inputs

Bar count 60
ma20 400.949
ma50 397.1982
close 416.54
prevClose 396.9
avgVolume20 965459
volumeRatio 1.97
changePercent 4.95

Metrics snapshot

close 416.54
volume 1900087
changePercent 4.95

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 58.8/110
Main rating 觀望
5D momentum v2 17/50
Score with momentum v2 75.8/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.8/5 · 良好

Dimension score 3.8/5
Dimension grade 良好

Sub-items

pbPoints 0.5
pePoints 0.5
epsPoints 0
roePoints 0.4
debtPoints 0.5
marginPoints 0
turnoverUsdM 791.4623
volumePoints 0.5
revenuePoints 0.6
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 10/20 · 較差

Dimension score 10/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 2.4
obvPoints 2.4
vwapPoints 2.4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.ELV
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 4.6/15 · 較差

Dimension score 4.6/15
Dimension grade 較差

Sub-items

vix

score 0

details

source twelvedata+fred
missing true
vixClose n/a

trend

score 0.8

details

qqq

ma20 716.5275
ma50 710.6122
name QQQ
close 708.69
points 0.4

spy

ma20 767.5585
ma50 758.2458
name SPY
close 757.83
points 0.4
source twelvedata+fred
atrPct 2.5148
atrPoints 3
cciPoints 0.8
vixPoints 0
marketTrendPoints 0.8

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 7.2/10 · 良好

Dimension score 7.2/10
Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 2.5148
turnoverUsdM 791.4623
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.8

stopLevels

symbol US.ELV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 395.59

strength_details

ma_score 2
atr_score 2
rsi_score 3
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.8
stop_loss_percent 5
take_profit_price 454.1802
target_multiplier 2.2
technical_strength 2.45
take_profit_percent 9
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.7894
stopLossPercent 5.0295
diversificationPoints 2

技術信號 — 25.2/30 · 優秀

Dimension score 25.2/30
Dimension grade 優秀

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 2.1
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 2.1
vcp_reason 波幅收縮(11.5%→6.2%);站上MA50;升放量(近10日3日);Ready=N;Confirm=Y

vcp_metrics

up_days 3
vol_ref 945860
down_days 6
vcp_ready false
above_ma50 true
avg_vol_10 972810
avg_vol_20 909790
avg_vol_30 945860
range_pct_10 0.0619
range_pct_20 0.0738
range_pct_30 0.115
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok false
up_expand_days 3
breakout_20d_ok false
vol_ratio_10_30 1.0285
dist_to_20d_high 0.0001
down_shrink_days 2
breakout_level_20d 416.58
vcp_breakout_confirm true
contraction_ratio_10_30 0.5383
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.7
rsiKdjPoints 4
volumeWeight 2
maCrossPoints 2.4
shortRsiPoints 1
shortMacdPoints 0.4
volConfirmPoints 1
volumePointsTechnical 1.2

情緒分析 — 6/10 · 一般

Dimension score 6/10
Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 4
sentimentScoreRaw 1.2

sentimentData

raw {"id":141950829,"url":"https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.","category":"company","datetime":1788876918,"headline":"2 Reasons to Watch ELV and 1 to Stay Cautious"}, {"id":141446869,"url":"https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...","category":"company","datetime":1788541717,"headline":"Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"}, {"id":141362847,"url":"https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]","category":"company","datetime":1788275973,"headline":"Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"}, {"id":141362854,"url":"https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]","category":"company","datetime":1788275589,"headline":"Elevance Health (ELV): Bridging the Gap between Care and Coverage"}, {"id":141348697,"url":"https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).","category":"company","datetime":1787941732,"headline":"Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"}, {"id":141348701,"url":"https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...","category":"company","datetime":1787757179,"headline":"Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"}, {"id":141348702,"url":"https://finnhub.io/api/news?id=2a90f9ffa47c2a658bb35ed845fdefe5b254645d20974fbff3f7fa488adff391","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health (ELV) drew fresh attention this week after its Carelon Behavioral Health unit appointed forensic psychiatrist Dr. Patrick Fox as leader, putting behavioral services for more than 61 million members under new oversight. Those leadership changes come as Elevance Health trades at US$398.87, with a 30 day share price return of 5.61% and year to date share price return of 12.60%. The 1 year total shareholder return of 31.36% contrasts with a 3 year total shareholder return that is...","category":"company","datetime":1787745974,"headline":"Elevance Health (ELV) Could Be 11% Undervalued As Carelon Names New Behavioral Health Leader"}, {"id":141348703,"url":"https://finnhub.io/api/news?id=249326dbb0ac108ed2dcd6a2970fc004980a25cf7513cfae72f642c8527d55f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2026. The letter can be downloaded here. The Sound Shore Fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) rose 10.48% and 10.58% in the second quarter of 2026, trailing the Russell 1000 Value Index’s 13.87% and the S&P […]","category":"company","datetime":1787685630,"headline":"Is Elevance Health (ELV) a Mispriced Opportunity?"}
raw_source {"id":142064801,"url":"https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.","category":"company","datetime":1789069012,"headline":"Should You Buy Elevance Health Stock For The Margin It Lost?"}, {"id":142064393,"url":"https://finnhub.io/api/news?id=7c28e78d9040a5cce97fe2b77384836940d53d535f5f71724541cccc657ad8ee","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ELV","summary":"Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.","category":"company","datetime":1789067101,"headline":"Thursday's session: top gainers and losers in the S&P500 index"}, {"id":142063328,"url":"https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.","category":"company","datetime":1789061100,"headline":"UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"}, {"id":142062620,"url":"https://finnhub.io/api/news?id=42d1713943407a8373594164c6027ae51524d6e82d99ced0e1abd43763cbc25b","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ELV","summary":"Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.","category":"company","datetime":1789058101,"headline":"What's going on in today's session: S&P500 movers"}, {"id":142064037,"url":"https://finnhub.io/api/news?id=57d493ab3351dc74de676b0cd87b6e9bd1621b6634e7636031016eeb9aed01a9","image":"https://cdn.benzinga.com/files/images/story/2026/09/10/Market--Down--Creative-Crash-Recession-C.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.","category":"company","datetime":1789050419,"headline":"Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High"}, {"id":142066812,"url":"https://finnhub.io/api/news?id=c3a8490e26f351d1f1e73fe0cfa27c4a9c9d2378d030b2065497eda26ab93539","image":"https://cdn.benzinga.com/files/images/story/2026/09/10/Elevance-Health-Photo-by-Jonathan-Weiss-.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.","category":"company","datetime":1789049583,"headline":"Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation"}, {"id":142060147,"url":"https://finnhub.io/api/news?id=10663dfaeed0ebff97aaefb390f63748c5ff769ad0026a71593c7860874b7688","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10. For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment. As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.","category":"company","datetime":1789038250,"headline":"Elevance Health Inc's Dividend Analysis"}, {"id":142066813,"url":"https://finnhub.io/api/news?id=75266bf8779312c3481306c942803f68b1d5d054daa55df5708350b7f3aa6de4","image":"","source":"Benzinga","related":"ELV","summary":"Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..","category":"company","datetime":1789021705,"headline":"Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est"}, {"id":142066814,"url":"https://finnhub.io/api/news?id=c83bfcfa124b06b727e41e969f3edbdbe6c30d149d6bbfaf7d6627840dccba4e","image":"","source":"Benzinga","related":"ELV","summary":"Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..","category":"company","datetime":1789021680,"headline":"Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est"}, {"id":142028659,"url":"https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.","category":"company","datetime":1788982210,"headline":"Why Is UNH Stock Trading At A Premium With The Slowest Growth?"}, {"id":142025949,"url":"https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.","category":"company","datetime":1788964814,"headline":"UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"}, {"id":141950829,"url":"https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.","category":"company","datetime":1788876918,"headline":"2 Reasons to Watch ELV and 1 to Stay Cautious"}, {"id":141546908,"url":"https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.","category":"company","datetime":1788642735,"headline":"Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."}, {"id":141485601,"url":"https://finnhub.io/api/news?id=a14fa2d71c991d1424c650e89ccc0365f647e29aec84a754bdf9a4133b2e0743","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Explore this week’s dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates.","category":"company","datetime":1788562641,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week September 6"}, {"id":141446869,"url":"https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...","category":"company","datetime":1788541717,"headline":"Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"}, {"id":141446662,"url":"https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.","category":"company","datetime":1788537840,"headline":"UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"}, {"id":141406653,"url":"https://finnhub.io/api/news?id=0fc4ece3606f4bc356908fcf90fe606852128b69087dfef8e68812e6877e4525","image":"","source":"SeekingAlpha","related":"ELV","summary":"","category":"company","datetime":1788468965,"headline":"Tracking Leon Cooperman's Omega Advisors Portfolio - Q2 2026 Update"}, {"id":141402794,"url":"https://finnhub.io/api/news?id=c5b2226aff37f7fdea42ffc0a3e08c7d47d198279f6393e69e1234a596a2456a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.","category":"company","datetime":1788456945,"headline":"UnitedHealth Stock Recovered Before Its Margins Did"}, {"id":141400357,"url":"https://finnhub.io/api/news?id=19b31dad684a09c10510e4d143d2601be86618c98904802e5c585553b6fe199e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.","category":"company","datetime":1788446735,"headline":"CVS Stock Has Left Its Peers Behind. Or Has It?"}, {"id":141376481,"url":"https://finnhub.io/api/news?id=c5142c9c5bbbb3009728f0775ed74e8ff2bb7da9ccaf6344e74f6c3910f5200e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.","category":"company","datetime":1788360360,"headline":"Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?"}, {"id":141379955,"url":"https://finnhub.io/api/news?id=9ee49755478826af4de84decd2b0c6ea28d749fc2ddb35d8a026a818d34b6a7c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health has underperformed its industry peers over the past year, but analysts are moderately optimistic about the stock’s prospects.","category":"company","datetime":1788353840,"headline":"How Is Elevance Health’s Stock Performance Compared to Other Health Providers?"}, {"id":141369881,"url":"https://finnhub.io/api/news?id=e4986c7e355043e59c656a1c52dbe0d2e2b30ebbe6e03009de611177fa730fe7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CNC's Marketplace recovery is boosting profitability as better pricing, medical cost trends and risk dynamics reshape its earnings outlook.","category":"company","datetime":1788281640,"headline":"Can Centene's Marketplace Recovery Fuel Stronger Earnings Growth?"}, {"id":141368964,"url":"https://finnhub.io/api/news?id=e5186e485dc68957760302a6c425447b90b006aca680e1528a0a389ed7c70459","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ELV","summary":"Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.","category":"company","datetime":1788280501,"headline":"Which S&P500 stocks are moving on Tuesday?"}, {"id":141362847,"url":"https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]","category":"company","datetime":1788275973,"headline":"Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"}, {"id":141362854,"url":"https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]","category":"company","datetime":1788275589,"headline":"Elevance Health (ELV): Bridging the Gap between Care and Coverage"}, {"id":141370499,"url":"https://finnhub.io/api/news?id=449bfd73faa2a0619ff0244e90ac9f9188892e5b55be042037046fe31ded0beb","image":"","source":"Benzinga","related":"ELV","summary":"https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss","category":"company","datetime":1788271464,"headline":"FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients"}, {"id":141369187,"url":"https://finnhub.io/api/news?id=efc3da274f0ad5bd69acce8293e14118c2980c701e25a977ad4af86808ec1c51","image":"https://cdn.benzinga.com/files/images/story/2026/09/01/New-York-Ny-Usa-march-21--2024-The-New-Y.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.","category":"company","datetime":1788267096,"headline":"Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today"}, {"id":141033408,"url":"https://finnhub.io/api/news?id=8ac2e8d39f09e3624d224617145a6038b10b9d9614d10aeb8b095fe16b9b65b8","image":"","source":"Benzinga","related":"ELV","summary":"","category":"company","datetime":1788263573,"headline":"Freenome shares are trading higher after the company announced FDA approval for its SimpleSreen CRC blood-based screening test."}, {"id":141361168,"url":"https://finnhub.io/api/news?id=1cbf7f516ca93aacdc4e94985c792cd793c6948f29279ace82eac658358e283e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.","category":"company","datetime":1788204328,"headline":"UNH Stock Gets Cheaper Only If The Margins Come Back"}, {"id":141348696,"url":"https://finnhub.io/api/news?id=e21e41f3ee9a082fe4b89d56b633a2d96bf0fff4264582b1399beef45b1bd20e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.","category":"company","datetime":1787943961,"headline":"Is CVS Stock Set for a Rebound?"}, {"id":141348697,"url":"https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).","category":"company","datetime":1787941732,"headline":"Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"}, {"id":141348698,"url":"https://finnhub.io/api/news?id=9cb7ab406e99ebb67666f4debc44ace31c983016f37660383b80409497e50f1b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787934624,"headline":"Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?"}, {"id":141348699,"url":"https://finnhub.io/api/news?id=7b9aaf0f06e7f13118a9e7ec9ec53b07edb5eb36492e127cd742bf487132234d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.","category":"company","datetime":1787876791,"headline":"Can a $68 Billion Payout Save UNH Stock?"}, {"id":141348700,"url":"https://finnhub.io/api/news?id=ab70e49cb3984bc11c8bfbdab7821b88357b14a0daba3b15666b8acbeca953a3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.","category":"company","datetime":1787844000,"headline":"Can Cigna's Smart Coverage Help Close Health-Cost Gaps?"}, {"id":141326656,"url":"https://finnhub.io/api/news?id=f0ee289a15577c07a4f88b461b3b9df0cab874642345723232053d6898832f08","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Ruane, Cunniff & Goldfarb Q2 2026 13F: key holdings, new buys & trims, and Sequoia Fund vs S&P 500. Read here for a detailed investment analysis.","category":"company","datetime":1787781184,"headline":"Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update"}, {"id":141348701,"url":"https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...","category":"company","datetime":1787757179,"headline":"Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"}, {"id":141348702,"url":"https://finnhub.io/api/news?id=2a90f9ffa47c2a658bb35ed845fdefe5b254645d20974fbff3f7fa488adff391","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health (ELV) drew fresh attention this week after its Carelon Behavioral Health unit appointed forensic psychiatrist Dr. Patrick Fox as leader, putting behavioral services for more than 61 million members under new oversight. Those leadership changes come as Elevance Health trades at US$398.87, with a 30 day share price return of 5.61% and year to date share price return of 12.60%. The 1 year total shareholder return of 31.36% contrasts with a 3 year total shareholder return that is...","category":"company","datetime":1787745974,"headline":"Elevance Health (ELV) Could Be 11% Undervalued As Carelon Names New Behavioral Health Leader"}, {"id":141348703,"url":"https://finnhub.io/api/news?id=249326dbb0ac108ed2dcd6a2970fc004980a25cf7513cfae72f642c8527d55f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2026. The letter can be downloaded here. The Sound Shore Fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) rose 10.48% and 10.58% in the second quarter of 2026, trailing the Russell 1000 Value Index’s 13.87% and the S&P […]","category":"company","datetime":1787685630,"headline":"Is Elevance Health (ELV) a Mispriced Opportunity?"}, {"id":141348704,"url":"https://finnhub.io/api/news?id=f579d4e655a1c6b3865758f2eb885d4aaf89fa1832205ed74d9d2c3be5f56e5d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.","category":"company","datetime":1787677080,"headline":"UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?"}, {"id":141348705,"url":"https://finnhub.io/api/news?id=a697839727b60d968b56f21ed5428c6d3e917c24657401be3326394a8688a31f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Dr. Patrick Fox, a forensic psychiatrist and health plan leader, will take the reins at Carelon Behavioral Services effective immediately. His experience will be “invaluable” for the unit, a top Elevance executive said.","category":"company","datetime":1787653665,"headline":"Elevance’s behavioral health division nabs new president"}, {"id":141348706,"url":"https://finnhub.io/api/news?id=151b0d4bdd9467e584b2144af927c6645c3f8a4360ead424569dce82f9058d54","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Medicare's improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.","category":"company","datetime":1787594668,"headline":"UnitedHealth Stock's Biggest Risk Sits In The Commercial Book"}, {"id":141348707,"url":"https://finnhub.io/api/news?id=7f5f74d99e12d15db763c6c22ab7d23ac40d8468ba28801a0634d10239c11e38","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Despite Elevance Health's outperformance relative to the broader market over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock's prospects.","category":"company","datetime":1787588640,"headline":"Elevance Health Stock Outlook: Is Wall Street Bullish or Bearish?"}, {"id":141278437,"url":"https://finnhub.io/api/news?id=b295eac02aec9c6a14a41b24daf8c516e0e5d52cc2f5cdffb36783e0ac4015ed","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.","category":"company","datetime":1787349486,"headline":"Is The Pullback In UNH Stock A Glitch Or A Warning?"}, {"id":141278439,"url":"https://finnhub.io/api/news?id=0aa4c6eab65e8fa1fe312f6d5ad967c837c98714d3987241138d505991dec443","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.","category":"company","datetime":1787333520,"headline":"Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?"}, {"id":141280264,"url":"https://finnhub.io/api/news?id=b6a7575647dc6c1fed55742c2871f075dcf6c8397314691554b3e8c20f9bd644","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Medpace (MEDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787329807,"headline":"Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?"}, {"id":141280265,"url":"https://finnhub.io/api/news?id=351df5c90b8bb6fd905405664cbbd083be75975fdd08673ee992605c35a59174","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.","category":"company","datetime":1787327027,"headline":"2 Large-Cap Stocks with Promising Prospects and 1 Facing Headwinds"}, {"id":141278449,"url":"https://finnhub.io/api/news?id=984f68cae88b01dc0468fddba0bc7fb289ae283fd6a8aabceb2bf6c887b1fa62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.","category":"company","datetime":1787244420,"headline":"Can Humana's Star Ratings Rebound Unlock MA Earnings Power?"}, {"id":141258963,"url":"https://finnhub.io/api/news?id=a415fc07907197a7f9360b6450ff2edea764c2626a17877f0e266de5b3e9d0aa","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.","category":"company","datetime":1787159760,"headline":"UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?"}, {"id":141258969,"url":"https://finnhub.io/api/news?id=26ee55577045b4e92bca2b6bf710487cb004891df4b903b1f9e22de1438efad0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"CVS delivers strong Q2 growth and raises 2026 targets, but Caremark pressures and medical costs are likely to shape its next move.","category":"company","datetime":1787060940,"headline":"How Should You Approach CVS Health Stock After Q2 Earnings?"}, {"id":141247734,"url":"https://finnhub.io/api/news?id=a607edaa23bb540143fdfe73de9dde5d38de54822e9469632d272690e461761a","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often","category":"company","datetime":1787060120,"headline":"10 Health Care Stocks Whale Activity In Today’s Session"}, {"id":141246630,"url":"https://finnhub.io/api/news?id=7a0923142f4e79f7c0843e127d5fe066087883fcfd22c32fedcef46c9704915e","image":"https://cdn.benzinga.com/files/images/story/2026/08/18/Tech-Stocks-Now-Valued-270-Higher-Than-A.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"Value investor Seth Klarman reveals his latest stock picks in a second quarter filing for hedge fund Baupost Group.","category":"company","datetime":1787053961,"headline":"Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2"}, {"id":141244705,"url":"https://finnhub.io/api/news?id=be80c4cb30856d289d827b5c8223d809a45988346066920470f0734de8ace71d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345765699/image_1345765699.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"In an ongoing trend, many leading managed care insurers saw shifts in membership, notably in the senior-focused, government-subsidized Medicare Advantage plans.","category":"company","datetime":1787028060,"headline":"U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership"}, {"id":141242335,"url":"https://finnhub.io/api/news?id=adf36bd6d8d33f0eda81a3ffe443bb9cac2a47726dfa0107317ec0ca23d0c555","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/166689266/image_166689266.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Baupost’s Q2 2026 13F: AMZN becomes top holding as stakes rise in GOOGL and others, with major sells too.","category":"company","datetime":1786996813,"headline":"Tracking Seth Klarman's Baupost Group Holdings - Q2 2026 Update"}, {"id":141267427,"url":"https://finnhub.io/api/news?id=987b4bba15a6381a37b79518478db8c80a113b5b0584ac92f0f5d05af124dd4b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Highlighted by clinical facility expansion from Acadia Healthcare and Universal Health Services (UHS), payer integration via Elevance Health (Carelon Behavioral Health), and digital therapy platform growth across BetterHelp (Teladoc Health), Talkspace, Calm, Lyra Health, and Spring Health, the industry is undergoing structural transformation. This study delivers a comprehensive evaluation of 24,696 mental health facilities operated by 14,554 companies, outpatient ($38.2 billion) versus inpatient","category":"company","datetime":1786964100,"headline":"U.S. Mental Health Treatment Market Report 2026–2030: Evaluating $159 Billion Forecast, Digital App Adoption, and Strategies of Acadia Healthcare, UHS, Talkspace, and Elevance Health"}, {"id":141231125,"url":"https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.","category":"company","datetime":1786867596,"headline":"IHF: Healthcare Dashboard For August"}, {"id":141280269,"url":"https://finnhub.io/api/news?id=962f24294af752e8b1f025463306dea606daacf829b54631aae90034c1dd410c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1786725003,"headline":"Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?"}, {"id":141216543,"url":"https://finnhub.io/api/news?id=8f90b1bf8a8ca0e19a08ee253d27540cd211eeea879286163b5557b466f1392d","image":"https://cdn.benzinga.com/files/images/story/2026/08/14/Los-Angeles---Jan-8-Mark-Cuban-At-The-Sp.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.","category":"company","datetime":1786700896,"headline":"Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs"}, {"id":141212229,"url":"https://finnhub.io/api/news?id=e4ad56c5a247f3370ef5959e508d3b3f2bcc51db1697df52bbcfdd0f09348767","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Elevance Health has delivered a 37.6% gain over the past year, yet current valuation checks still lean on the side of the stock looking inexpensive rather than stretched. For investors, that creates a pricing debate around how much of the company’s recent health data partnerships and care model initiatives is already reflected in today’s US$398.22 share price. Over the last 12 months Elevance Health is up 37.6%. This puts recent shareholders in a comfortable spot and raises the bar for what...","category":"company","datetime":1786662858,"headline":"Is Elevance Health (ELV) Still A Bargain After A 38% Gain?"}, {"id":141212158,"url":"https://finnhub.io/api/news?id=7730b8ebf9b742cb0c5a753f4df1250af1c36bbe10f7ecea337020be3c81ade8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Management had named the plan exits, the Medicare margin target and the repricing date before the run began.","category":"company","datetime":1786657819,"headline":"The Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan"}, {"id":141210847,"url":"https://finnhub.io/api/news?id=42e28496e7f2ad2a5db1e407f5aca83207b3828c59271f2bb0658ea61a3ce6d4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"Management has raised its full-year earnings outlook twice, and the segment doing most of the lifting is still short of its own target margin.","category":"company","datetime":1786655397,"headline":"CVS Health Stock's Next Leg Sits In Aetna's Unfinished Margin Repair"}, {"id":141206528,"url":"https://finnhub.io/api/news?id=36b24b9c3cd2bcb170d4b9cb46edc04af33246eae0a534d75da78a3d291365a0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"HUM's HealthStream deal backs 1,000 caregiver scholarships and new tools to improve recruitment and retention in Indiana.","category":"company","datetime":1786630620,"headline":"Can Humana Improve Caregiver Retention With HealthStream Deal?"}, {"id":141203899,"url":"https://finnhub.io/api/news?id=189125c65d2ebcacca14cb777c1c68971d225165806b5eb0196a097a06b428b1","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2230767136/image_2230767136.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ELV","summary":"Key contributors include Texas Instruments, Humana, and Nucor. Click here to read more.","category":"company","datetime":1786597200,"headline":"Diamond Hill Large Cap Fund Q2 2026 Portfolio Update"}, {"id":141200722,"url":"https://finnhub.io/api/news?id=6febca7c9f81660b2c4157b251a0e3bd195d405f91d75513e2b654b79aaa8f35","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"UnitedHealth's lower medical costs are fueling an earnings recovery, but rising commercial costs and 2027 pricing decisions could test its durability.","category":"company","datetime":1786559580,"headline":"Can UNH's Lower Medical Costs Sustain the Earnings Recovery?"}, {"id":141194603,"url":"https://finnhub.io/api/news?id=e239e42b732188ca7b851e111a440215ab9cdc197a501d0d5abc0d3274a14b74","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will","category":"company","datetime":1786541715,"headline":"10 Health Care Stocks With Whale Alerts In Today’s Session"}, {"id":141201645,"url":"https://finnhub.io/api/news?id=d3eb33199eb9a97b9dde2c4cc4c1c6195a074de3e610f599c2bb3ed2495be9cc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ELV","summary":"BOSTON, August 11, 2026--Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, today announced a strategic partnership that gives life sciences researchers and data analysts secure, scalable access to high-quality, analysis-ready, real-world data in a protected environment, enabling faster, evidence-based decision-making.","category":"company","datetime":1786447800,"headline":"Carelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences Researchers"}, {"id":141184788,"url":"https://finnhub.io/api/news?id=ae2bb843f1f9e99dca127f357933c6c758b8933eb937c5bfa96078361b9984de","image":"https://cdn.benzinga.com/files/images/story/2026/08/11/Los-Angeles---Jan-8-Mark-Cuban-At-The-Sp.jpg?width=2048&height=1536","source":"Benzinga","related":"ELV","summary":"Mark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.","category":"company","datetime":1786422511,"headline":"Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 4
recomputed_at_score true
sentiment_score_raw 1.2
source_article_count 66
discarded_article_count 56
sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.8 5/110 76% 3.8
資金流 10 20/110 50% 10
市場環境 4.6 15/110 30.67% 4.6
催化劑 2 20/110 10% 2
風險管理 7.2 10/110 72% 7.2
技術信號 25.2 30/110 84% 25.2
情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 17/50
ret_5d 0.0264
max_score 50
max_total 50
raw_total 17
vcp_bonus 0
vol_ratio 2.0885
ret_points 4
vol_points 8
range_ratio 1.5594
volat_points 4
day_range_pct 0.0349
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.5148
turnoverUsdM 791.4623
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.8

stopLevels

symbol US.ELV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 395.59

strength_details

ma_score 2
atr_score 2
rsi_score 3
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.8
stop_loss_percent 5
take_profit_price 454.1802
target_multiplier 2.2
technical_strength 2.45
take_profit_percent 9
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.7894
stopLossPercent 5.0295
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.8/5分
資金流分析總分: 10/20分
市場環境分析總分: 4.6/15分
催化劑分析: 2/20分
風險管理總分: 7.2/10分
技術信號分析總分: 25.2/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 10.475
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.51
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 223.46
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.1122
kdj
d 56.41
j 64.01
k 58.94
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 53.26
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 6
trend 有流入
value 4139887
recentSlope 4198.7
previousSlope 184950
rsi
value 62.13
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 392.8013
position SAR喺價下
distancePct 5.7
previousTrend 上升
ma50
value 397.1982
macd
macd 3.752
trend 強烈看漲
signal 2.9016
histogram 0.8505
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 6
value 402.3155
position 連續1-2日>VWAP
consecutiveAbove 1
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.97
score 6
avgVolume 965459
currentVolume 1900087
derived
ma20 400.949
ma50 397.1982
prevClose 396.9
avgVolume10 1094439
avgVolume20 965459
changePercent 4.95
avgVolumeForScore 965459
ma_cross
ma20 400.949
ma50 397.1982
rule Cursor_18.24 MA20/MA50 cross
cross 接近
score 6
prevMa20 400.079
prevMa50 396.602
spreadPct 0.94
isVolumeBreakout true
bollinger
lower 388.2435
upper 413.6545
position 上半部
rsi_short
value 63.7
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.97

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.5147644280317754,
        "turnoverUsdM": 791.46225798087,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.ELV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 395.59,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.8,
      "stop_loss_percent": 5,
      "take_profit_price": 454.1802,
      "target_multiplier": 2.2,
      "technical_strength": 2.45,
      "take_profit_percent": 9
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.7894320238663484,
    "stopLossPercent": 5.029528856063551,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 75.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 17
  },
  "market": {
    "ma20": 400.949,
    "ma50": 397.1982,
    "close": 416.54,
    "prevClose": 396.9,
    "avgVolume20": 965459,
    "volumeRatio": 1.97,
    "changePercent": 4.95
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 17,
    "details": {
      "ret_5d": 0.02636509461856895,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 17,
      "vcp_bonus": 0,
      "vol_ratio": 2.088489651458029,
      "ret_points": 4,
      "vol_points": 8,
      "range_ratio": 1.5593716295211304,
      "volat_points": 4,
      "day_range_pct": 0.03485857216933376,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 75.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 76,
        "contribution": 3.8
      },
      {
        "raw": 10,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 4.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 30.67,
        "contribution": 4.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 25.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 84,
        "contribution": 25.2
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "觀望",
    "result": 58.8,
    "details": [
      "基本面分析總分: 3.8/5分",
      "資金流分析總分: 10/20分",
      "市場環境分析總分: 4.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 25.2/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.8,
      "資金流": 10,
      "市場環境": 4.6,
      "情緒分析": 6,
      "技術信號": 25.2,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 791.46225798087,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 2.4,
          "vwapPoints": 2.4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ELV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 716.52749955,
                "ma50": 710.6121986999997,
                "name": "QQQ",
                "close": 708.69,
                "points": 0.4
              },
              "spy": {
                "ma20": 767.5584954500001,
                "ma50": 758.2458016200002,
                "name": "SPY",
                "close": 757.83002,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.5147644280317754,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141950829,
                "url": "https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788876918,
                "headline": "2 Reasons to Watch ELV and 1 to Stay Cautious"
              },
              {
                "id": 141446869,
                "url": "https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...",
                "category": "company",
                "datetime": 1788541717,
                "headline": "Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"
              },
              {
                "id": 141362847,
                "url": "https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]",
                "category": "company",
                "datetime": 1788275973,
                "headline": "Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"
              },
              {
                "id": 141362854,
                "url": "https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]",
                "category": "company",
                "datetime": 1788275589,
                "headline": "Elevance Health (ELV): Bridging the Gap between Care and Coverage"
              },
              {
                "id": 141348697,
                "url": "https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).",
                "category": "company",
                "datetime": 1787941732,
                "headline": "Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"
              },
              {
                "id": 141348701,
                "url": "https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...",
                "category": "company",
                "datetime": 1787757179,
                "headline": "Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"
              },
              {
                "id": 141348702,
                "url": "https://finnhub.io/api/news?id=2a90f9ffa47c2a658bb35ed845fdefe5b254645d20974fbff3f7fa488adff391",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) drew fresh attention this week after its Carelon Behavioral Health unit appointed forensic psychiatrist Dr. Patrick Fox as leader, putting behavioral services for more than 61 million members under new oversight. Those leadership changes come as Elevance Health trades at US$398.87, with a 30 day share price return of 5.61% and year to date share price return of 12.60%. The 1 year total shareholder return of 31.36% contrasts with a 3 year total shareholder return that is...",
                "category": "company",
                "datetime": 1787745974,
                "headline": "Elevance Health (ELV) Could Be 11% Undervalued As Carelon Names New Behavioral Health Leader"
              },
              {
                "id": 141348703,
                "url": "https://finnhub.io/api/news?id=249326dbb0ac108ed2dcd6a2970fc004980a25cf7513cfae72f642c8527d55f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2026. The letter can be downloaded here. The Sound Shore Fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) rose 10.48% and 10.58% in the second quarter of 2026, trailing the Russell 1000 Value Index’s 13.87% and the S&P […]",
                "category": "company",
                "datetime": 1787685630,
                "headline": "Is Elevance Health (ELV) a Mispriced Opportunity?"
              }
            ],
            "raw_source": [
              {
                "id": 142064801,
                "url": "https://finnhub.io/api/news?id=986a6117d59e8175d3255bd7bd52028ee01dd339371ca80d62205c5bea18363a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.",
                "category": "company",
                "datetime": 1789069012,
                "headline": "Should You Buy Elevance Health Stock For The Margin It Lost?"
              },
              {
                "id": 142064393,
                "url": "https://finnhub.io/api/news?id=7c28e78d9040a5cce97fe2b77384836940d53d535f5f71724541cccc657ad8ee",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1789067101,
                "headline": "Thursday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 142063328,
                "url": "https://finnhub.io/api/news?id=0ddaecaced7b45415c54683e8f459cfc0dd0f482dcb3ec10e83497f59326cbf3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.",
                "category": "company",
                "datetime": 1789061100,
                "headline": "UnitedHealth Reshapes Florida WellMed Operations With TPG Deal"
              },
              {
                "id": 142062620,
                "url": "https://finnhub.io/api/news?id=42d1713943407a8373594164c6027ae51524d6e82d99ced0e1abd43763cbc25b",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1789058101,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 142064037,
                "url": "https://finnhub.io/api/news?id=57d493ab3351dc74de676b0cd87b6e9bd1621b6634e7636031016eeb9aed01a9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Market--Down--Creative-Crash-Recession-C.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.",
                "category": "company",
                "datetime": 1789050419,
                "headline": "Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High"
              },
              {
                "id": 142066812,
                "url": "https://finnhub.io/api/news?id=c3a8490e26f351d1f1e73fe0cfa27c4a9c9d2378d030b2065497eda26ab93539",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Elevance-Health-Photo-by-Jonathan-Weiss-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.",
                "category": "company",
                "datetime": 1789049583,
                "headline": "Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation"
              },
              {
                "id": 142060147,
                "url": "https://finnhub.io/api/news?id=10663dfaeed0ebff97aaefb390f63748c5ff769ad0026a71593c7860874b7688",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10.  For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment.  As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.",
                "category": "company",
                "datetime": 1789038250,
                "headline": "Elevance Health Inc's Dividend Analysis"
              },
              {
                "id": 142066813,
                "url": "https://finnhub.io/api/news?id=75266bf8779312c3481306c942803f68b1d5d054daa55df5708350b7f3aa6de4",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..",
                "category": "company",
                "datetime": 1789021705,
                "headline": "Elevance Health Affirms FY2026  GAAP EPS expected to be more than $20.10 vs $20.26 Est"
              },
              {
                "id": 142066814,
                "url": "https://finnhub.io/api/news?id=c83bfcfa124b06b727e41e969f3edbdbe6c30d149d6bbfaf7d6627840dccba4e",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..",
                "category": "company",
                "datetime": 1789021680,
                "headline": "Elevance Health Affirms FY2026  Adj EPS expected to be more than $27.00 vs $26.91 Est"
              },
              {
                "id": 142028659,
                "url": "https://finnhub.io/api/news?id=0081c272b61c689e1879a429e5f7c5cd199146ca47c277f5122abab9309cdee1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.",
                "category": "company",
                "datetime": 1788982210,
                "headline": "Why Is UNH Stock Trading At A Premium With The Slowest Growth?"
              },
              {
                "id": 142025949,
                "url": "https://finnhub.io/api/news?id=1e60277542dd68ec98f2ca5040753093f4e61bd880edcdf64de9408c92768f2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.",
                "category": "company",
                "datetime": 1788964814,
                "headline": "UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation"
              },
              {
                "id": 141950829,
                "url": "https://finnhub.io/api/news?id=0d6a03820241bbbe5b1f009058d13066016bbfb4577f67b0d52a1150f1e424ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788876918,
                "headline": "2 Reasons to Watch ELV and 1 to Stay Cautious"
              },
              {
                "id": 141546908,
                "url": "https://finnhub.io/api/news?id=8e571c6258a78e295e3d3b62ceae232f24f7212af2894b0de642b2676a6a05ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.",
                "category": "company",
                "datetime": 1788642735,
                "headline": "Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2."
              },
              {
                "id": 141485601,
                "url": "https://finnhub.io/api/news?id=a14fa2d71c991d1424c650e89ccc0365f647e29aec84a754bdf9a4133b2e0743",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Explore this week’s dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates.",
                "category": "company",
                "datetime": 1788562641,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 6"
              },
              {
                "id": 141446869,
                "url": "https://finnhub.io/api/news?id=f83be2ff10be414db328b84762aa96c3abb7549d3caafc3d998c02964c8ed095",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...",
                "category": "company",
                "datetime": 1788541717,
                "headline": "Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run"
              },
              {
                "id": 141446662,
                "url": "https://finnhub.io/api/news?id=5d83f5780b6dfb902bdb5621ef012795ad52a453dd0b77ba71da028ec44295d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.",
                "category": "company",
                "datetime": 1788537840,
                "headline": "UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?"
              },
              {
                "id": 141406653,
                "url": "https://finnhub.io/api/news?id=0fc4ece3606f4bc356908fcf90fe606852128b69087dfef8e68812e6877e4525",
                "image": "",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "",
                "category": "company",
                "datetime": 1788468965,
                "headline": "Tracking Leon Cooperman's Omega Advisors Portfolio - Q2 2026 Update"
              },
              {
                "id": 141402794,
                "url": "https://finnhub.io/api/news?id=c5b2226aff37f7fdea42ffc0a3e08c7d47d198279f6393e69e1234a596a2456a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.",
                "category": "company",
                "datetime": 1788456945,
                "headline": "UnitedHealth Stock Recovered Before Its Margins Did"
              },
              {
                "id": 141400357,
                "url": "https://finnhub.io/api/news?id=19b31dad684a09c10510e4d143d2601be86618c98904802e5c585553b6fe199e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.",
                "category": "company",
                "datetime": 1788446735,
                "headline": "CVS Stock Has Left Its Peers Behind. Or Has It?"
              },
              {
                "id": 141376481,
                "url": "https://finnhub.io/api/news?id=c5142c9c5bbbb3009728f0775ed74e8ff2bb7da9ccaf6344e74f6c3910f5200e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.",
                "category": "company",
                "datetime": 1788360360,
                "headline": "Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?"
              },
              {
                "id": 141379955,
                "url": "https://finnhub.io/api/news?id=9ee49755478826af4de84decd2b0c6ea28d749fc2ddb35d8a026a818d34b6a7c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has underperformed its industry peers over the past year, but analysts are moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1788353840,
                "headline": "How Is Elevance Health’s Stock Performance Compared to Other Health Providers?"
              },
              {
                "id": 141369881,
                "url": "https://finnhub.io/api/news?id=e4986c7e355043e59c656a1c52dbe0d2e2b30ebbe6e03009de611177fa730fe7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CNC's Marketplace recovery is boosting profitability as better pricing, medical cost trends and risk dynamics reshape its earnings outlook.",
                "category": "company",
                "datetime": 1788281640,
                "headline": "Can Centene's Marketplace Recovery Fuel Stronger Earnings Growth?"
              },
              {
                "id": 141368964,
                "url": "https://finnhub.io/api/news?id=e5186e485dc68957760302a6c425447b90b006aca680e1528a0a389ed7c70459",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ELV",
                "summary": "Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1788280501,
                "headline": "Which S&P500 stocks are moving on Tuesday?"
              },
              {
                "id": 141362847,
                "url": "https://finnhub.io/api/news?id=46baef09383f41e21789fc2b3f9168ff7c68bd6636fa6ff9171ecead1c90b74f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "First Eagle Investment Management, an investment management company, released its Q2 2026 investor update for “First Eagle Global Fund”. The letter can be downloaded here. Easing tensions in the Middle East led to a strong rally in risk markets in Q2. The S&P 500 Index rose 15.2%, while the MSCI EAFE Index gained 10.8%. Growth […]",
                "category": "company",
                "datetime": 1788275973,
                "headline": "Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability"
              },
              {
                "id": 141362854,
                "url": "https://finnhub.io/api/news?id=04bd634a8b988a7cf311da2f49c8a860042d2747c93fb4b91b297dd3b8756cb9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Large Cap Fundamental Value Fund.” A copy can be downloaded here. Equity markets posted strong returns, with the Russell 1000 Value Index rising by 13.9%, although many individual stocks lagged. Notably, semiconductor stocks and AI-related sectors saw exceptional gains. The rally […]",
                "category": "company",
                "datetime": 1788275589,
                "headline": "Elevance Health (ELV): Bridging the Gap between Care and Coverage"
              },
              {
                "id": 141370499,
                "url": "https://finnhub.io/api/news?id=449bfd73faa2a0619ff0244e90ac9f9188892e5b55be042037046fe31ded0beb",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss",
                "category": "company",
                "datetime": 1788271464,
                "headline": "FDA Says It Has Received 990 Adverse Event Reports Tied To Compounded Semaglutide And More Than 730 Tied To Compounded Tirzepatide; Establishes Import Alert For Compounded GLP-1 Active Pharmaceutical Ingredients"
              },
              {
                "id": 141369187,
                "url": "https://finnhub.io/api/news?id=efc3da274f0ad5bd69acce8293e14118c2980c701e25a977ad4af86808ec1c51",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/01/New-York-Ny-Usa-march-21--2024-The-New-Y.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.",
                "category": "company",
                "datetime": 1788267096,
                "headline": "Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today"
              },
              {
                "id": 141033408,
                "url": "https://finnhub.io/api/news?id=8ac2e8d39f09e3624d224617145a6038b10b9d9614d10aeb8b095fe16b9b65b8",
                "image": "",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "",
                "category": "company",
                "datetime": 1788263573,
                "headline": "Freenome shares are trading higher after the company announced FDA approval for its SimpleSreen CRC blood-based screening test."
              },
              {
                "id": 141361168,
                "url": "https://finnhub.io/api/news?id=1cbf7f516ca93aacdc4e94985c792cd793c6948f29279ace82eac658358e283e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.",
                "category": "company",
                "datetime": 1788204328,
                "headline": "UNH Stock Gets Cheaper Only If The Margins Come Back"
              },
              {
                "id": 141348696,
                "url": "https://finnhub.io/api/news?id=e21e41f3ee9a082fe4b89d56b633a2d96bf0fff4264582b1399beef45b1bd20e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Its market-shock drawdowns have been ordinary in depth, and some of its longest waits back to the old high came after falls the index barely noticed.",
                "category": "company",
                "datetime": 1787943961,
                "headline": "Is CVS Stock Set for a Rebound?"
              },
              {
                "id": 141348697,
                "url": "https://finnhub.io/api/news?id=c3f11e3694dec0eb71a42656056e64871a363c44dc7c14ca74f28033388e390f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with Elevance Health (NYSE:ELV).",
                "category": "company",
                "datetime": 1787941732,
                "headline": "Health Insurance Providers Stocks Q2 In Review: Elevance Health (NYSE:ELV) Vs Peers"
              },
              {
                "id": 141348698,
                "url": "https://finnhub.io/api/news?id=9cb7ab406e99ebb67666f4debc44ace31c983016f37660383b80409497e50f1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787934624,
                "headline": "Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141348699,
                "url": "https://finnhub.io/api/news?id=7b9aaf0f06e7f13118a9e7ec9ec53b07edb5eb36492e127cd742bf487132234d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.",
                "category": "company",
                "datetime": 1787876791,
                "headline": "Can a $68 Billion Payout Save UNH Stock?"
              },
              {
                "id": 141348700,
                "url": "https://finnhub.io/api/news?id=ab70e49cb3984bc11c8bfbdab7821b88357b14a0daba3b15666b8acbeca953a3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.",
                "category": "company",
                "datetime": 1787844000,
                "headline": "Can Cigna's Smart Coverage Help Close Health-Cost Gaps?"
              },
              {
                "id": 141326656,
                "url": "https://finnhub.io/api/news?id=f0ee289a15577c07a4f88b461b3b9df0cab874642345723232053d6898832f08",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Ruane, Cunniff & Goldfarb Q2 2026 13F: key holdings, new buys & trims, and Sequoia Fund vs S&P 500. Read here for a detailed investment analysis.",
                "category": "company",
                "datetime": 1787781184,
                "headline": "Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update"
              },
              {
                "id": 141348701,
                "url": "https://finnhub.io/api/news?id=ba59e6db11547a74cca1b53900d2a5fa3b6d53f4b318ab658e604a859899faf5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "In recent weeks, Elevance Health has been highlighted for strong Q2 2026 results, raised full-year guidance, and operational gains driven by AI-enabled efficiency and cost savings. At the same time, the appointment of Dr. Patrick Fox to lead Carelon Behavioral Services underscores Elevance Health’s emphasis on behavioral health capabilities within its broader health services platform. Next, we’ll examine how Elevance’s AI-driven margin improvements and refreshed behavioral health leadership...",
                "category": "company",
                "datetime": 1787757179,
                "headline": "Did AI-Driven Margins and New Behavioral Health Leadership Just Shift Elevance Health's (ELV) Investment Narrative?"
              },
              {
                "id": 141348702,
                "url": "https://finnhub.io/api/news?id=2a90f9ffa47c2a658bb35ed845fdefe5b254645d20974fbff3f7fa488adff391",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) drew fresh attention this week after its Carelon Behavioral Health unit appointed forensic psychiatrist Dr. Patrick Fox as leader, putting behavioral services for more than 61 million members under new oversight. Those leadership changes come as Elevance Health trades at US$398.87, with a 30 day share price return of 5.61% and year to date share price return of 12.60%. The 1 year total shareholder return of 31.36% contrasts with a 3 year total shareholder return that is...",
                "category": "company",
                "datetime": 1787745974,
                "headline": "Elevance Health (ELV) Could Be 11% Undervalued As Carelon Names New Behavioral Health Leader"
              },
              {
                "id": 141348703,
                "url": "https://finnhub.io/api/news?id=249326dbb0ac108ed2dcd6a2970fc004980a25cf7513cfae72f642c8527d55f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2026. The letter can be downloaded here. The Sound Shore Fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) rose 10.48% and 10.58% in the second quarter of 2026, trailing the Russell 1000 Value Index’s 13.87% and the S&P […]",
                "category": "company",
                "datetime": 1787685630,
                "headline": "Is Elevance Health (ELV) a Mispriced Opportunity?"
              },
              {
                "id": 141348704,
                "url": "https://finnhub.io/api/news?id=f579d4e655a1c6b3865758f2eb885d4aaf89fa1832205ed74d9d2c3be5f56e5d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.",
                "category": "company",
                "datetime": 1787677080,
                "headline": "UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?"
              },
              {
                "id": 141348705,
                "url": "https://finnhub.io/api/news?id=a697839727b60d968b56f21ed5428c6d3e917c24657401be3326394a8688a31f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Dr. Patrick Fox, a forensic psychiatrist and health plan leader, will take the reins at Carelon Behavioral Services effective immediately. His experience will be “invaluable” for the unit, a top Elevance executive said.",
                "category": "company",
                "datetime": 1787653665,
                "headline": "Elevance’s behavioral health division nabs new president"
              },
              {
                "id": 141348706,
                "url": "https://finnhub.io/api/news?id=151b0d4bdd9467e584b2144af927c6645c3f8a4360ead424569dce82f9058d54",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Medicare's improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.",
                "category": "company",
                "datetime": 1787594668,
                "headline": "UnitedHealth Stock's Biggest Risk Sits In The Commercial Book"
              },
              {
                "id": 141348707,
                "url": "https://finnhub.io/api/news?id=7f5f74d99e12d15db763c6c22ab7d23ac40d8468ba28801a0634d10239c11e38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Despite Elevance Health's outperformance relative to the broader market over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock's prospects.",
                "category": "company",
                "datetime": 1787588640,
                "headline": "Elevance Health Stock Outlook: Is Wall Street Bullish or Bearish?"
              },
              {
                "id": 141278437,
                "url": "https://finnhub.io/api/news?id=b295eac02aec9c6a14a41b24daf8c516e0e5d52cc2f5cdffb36783e0ac4015ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.",
                "category": "company",
                "datetime": 1787349486,
                "headline": "Is The Pullback In UNH Stock A Glitch Or A Warning?"
              },
              {
                "id": 141278439,
                "url": "https://finnhub.io/api/news?id=0aa4c6eab65e8fa1fe312f6d5ad967c837c98714d3987241138d505991dec443",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.",
                "category": "company",
                "datetime": 1787333520,
                "headline": "Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?"
              },
              {
                "id": 141280264,
                "url": "https://finnhub.io/api/news?id=b6a7575647dc6c1fed55742c2871f075dcf6c8397314691554b3e8c20f9bd644",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Medpace (MEDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787329807,
                "headline": "Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?"
              },
              {
                "id": 141280265,
                "url": "https://finnhub.io/api/news?id=351df5c90b8bb6fd905405664cbbd083be75975fdd08673ee992605c35a59174",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
                "category": "company",
                "datetime": 1787327027,
                "headline": "2 Large-Cap Stocks with Promising Prospects and 1 Facing Headwinds"
              },
              {
                "id": 141278449,
                "url": "https://finnhub.io/api/news?id=984f68cae88b01dc0468fddba0bc7fb289ae283fd6a8aabceb2bf6c887b1fa62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.",
                "category": "company",
                "datetime": 1787244420,
                "headline": "Can Humana's Star Ratings Rebound Unlock MA Earnings Power?"
              },
              {
                "id": 141258963,
                "url": "https://finnhub.io/api/news?id=a415fc07907197a7f9360b6450ff2edea764c2626a17877f0e266de5b3e9d0aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.",
                "category": "company",
                "datetime": 1787159760,
                "headline": "UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?"
              },
              {
                "id": 141258969,
                "url": "https://finnhub.io/api/news?id=26ee55577045b4e92bca2b6bf710487cb004891df4b903b1f9e22de1438efad0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "CVS delivers strong Q2 growth and raises 2026 targets, but Caremark pressures and medical costs are likely to shape its next move.",
                "category": "company",
                "datetime": 1787060940,
                "headline": "How Should You Approach CVS Health Stock After Q2 Earnings?"
              },
              {
                "id": 141247734,
                "url": "https://finnhub.io/api/news?id=a607edaa23bb540143fdfe73de9dde5d38de54822e9469632d272690e461761a",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1787060120,
                "headline": "10 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 141246630,
                "url": "https://finnhub.io/api/news?id=7a0923142f4e79f7c0843e127d5fe066087883fcfd22c32fedcef46c9704915e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/18/Tech-Stocks-Now-Valued-270-Higher-Than-A.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Value investor Seth Klarman reveals his latest stock picks in a second quarter filing for hedge fund Baupost Group.",
                "category": "company",
                "datetime": 1787053961,
                "headline": "Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2"
              },
              {
                "id": 141244705,
                "url": "https://finnhub.io/api/news?id=be80c4cb30856d289d827b5c8223d809a45988346066920470f0734de8ace71d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345765699/image_1345765699.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "In an ongoing trend, many leading managed care insurers saw shifts in membership, notably in the senior-focused, government-subsidized Medicare Advantage plans.",
                "category": "company",
                "datetime": 1787028060,
                "headline": "U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership"
              },
              {
                "id": 141242335,
                "url": "https://finnhub.io/api/news?id=adf36bd6d8d33f0eda81a3ffe443bb9cac2a47726dfa0107317ec0ca23d0c555",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/166689266/image_166689266.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Baupost’s Q2 2026 13F: AMZN becomes top holding as stakes rise in GOOGL and others, with major sells too.",
                "category": "company",
                "datetime": 1786996813,
                "headline": "Tracking Seth Klarman's Baupost Group Holdings - Q2 2026 Update"
              },
              {
                "id": 141267427,
                "url": "https://finnhub.io/api/news?id=987b4bba15a6381a37b79518478db8c80a113b5b0584ac92f0f5d05af124dd4b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Highlighted by clinical facility expansion from Acadia Healthcare and Universal Health Services (UHS), payer integration via Elevance Health (Carelon Behavioral Health), and digital therapy platform growth across BetterHelp (Teladoc Health), Talkspace, Calm, Lyra Health, and Spring Health, the industry is undergoing structural transformation. This study delivers a comprehensive evaluation of 24,696 mental health facilities operated by 14,554 companies, outpatient ($38.2 billion) versus inpatient",
                "category": "company",
                "datetime": 1786964100,
                "headline": "U.S. Mental Health Treatment Market Report 2026–2030: Evaluating $159 Billion Forecast, Digital App Adoption, and Strategies of Acadia Healthcare, UHS, Talkspace, and Elevance Health"
              },
              {
                "id": 141231125,
                "url": "https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.",
                "category": "company",
                "datetime": 1786867596,
                "headline": "IHF: Healthcare Dashboard For August"
              },
              {
                "id": 141280269,
                "url": "https://finnhub.io/api/news?id=962f24294af752e8b1f025463306dea606daacf829b54631aae90034c1dd410c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1786725003,
                "headline": "Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141216543,
                "url": "https://finnhub.io/api/news?id=8f90b1bf8a8ca0e19a08ee253d27540cd211eeea879286163b5557b466f1392d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/14/Los-Angeles---Jan-8-Mark-Cuban-At-The-Sp.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.",
                "category": "company",
                "datetime": 1786700896,
                "headline": "Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs"
              },
              {
                "id": 141212229,
                "url": "https://finnhub.io/api/news?id=e4ad56c5a247f3370ef5959e508d3b3f2bcc51db1697df52bbcfdd0f09348767",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Elevance Health has delivered a 37.6% gain over the past year, yet current valuation checks still lean on the side of the stock looking inexpensive rather than stretched. For investors, that creates a pricing debate around how much of the company’s recent health data partnerships and care model initiatives is already reflected in today’s US$398.22 share price. Over the last 12 months Elevance Health is up 37.6%. This puts recent shareholders in a comfortable spot and raises the bar for what...",
                "category": "company",
                "datetime": 1786662858,
                "headline": "Is Elevance Health (ELV) Still A Bargain After A 38% Gain?"
              },
              {
                "id": 141212158,
                "url": "https://finnhub.io/api/news?id=7730b8ebf9b742cb0c5a753f4df1250af1c36bbe10f7ecea337020be3c81ade8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Management had named the plan exits, the Medicare margin target and the repricing date before the run began.",
                "category": "company",
                "datetime": 1786657819,
                "headline": "The Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan"
              },
              {
                "id": 141210847,
                "url": "https://finnhub.io/api/news?id=42e28496e7f2ad2a5db1e407f5aca83207b3828c59271f2bb0658ea61a3ce6d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "Management has raised its full-year earnings outlook twice, and the segment doing most of the lifting is still short of its own target margin.",
                "category": "company",
                "datetime": 1786655397,
                "headline": "CVS Health Stock's Next Leg Sits In Aetna's Unfinished Margin Repair"
              },
              {
                "id": 141206528,
                "url": "https://finnhub.io/api/news?id=36b24b9c3cd2bcb170d4b9cb46edc04af33246eae0a534d75da78a3d291365a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "HUM's HealthStream deal backs 1,000 caregiver scholarships and new tools to improve recruitment and retention in Indiana.",
                "category": "company",
                "datetime": 1786630620,
                "headline": "Can Humana Improve Caregiver Retention With HealthStream Deal?"
              },
              {
                "id": 141203899,
                "url": "https://finnhub.io/api/news?id=189125c65d2ebcacca14cb777c1c68971d225165806b5eb0196a097a06b428b1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2230767136/image_2230767136.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ELV",
                "summary": "Key contributors include Texas Instruments, Humana, and Nucor. Click here to read more.",
                "category": "company",
                "datetime": 1786597200,
                "headline": "Diamond Hill Large Cap Fund Q2 2026 Portfolio Update"
              },
              {
                "id": 141200722,
                "url": "https://finnhub.io/api/news?id=6febca7c9f81660b2c4157b251a0e3bd195d405f91d75513e2b654b79aaa8f35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "UnitedHealth's lower medical costs are fueling an earnings recovery, but rising commercial costs and 2027 pricing decisions could test its durability.",
                "category": "company",
                "datetime": 1786559580,
                "headline": "Can UNH's Lower Medical Costs Sustain the Earnings Recovery?"
              },
              {
                "id": 141194603,
                "url": "https://finnhub.io/api/news?id=e239e42b732188ca7b851e111a440215ab9cdc197a501d0d5abc0d3274a14b74",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1786541715,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 141201645,
                "url": "https://finnhub.io/api/news?id=d3eb33199eb9a97b9dde2c4cc4c1c6195a074de3e610f599c2bb3ed2495be9cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ELV",
                "summary": "BOSTON, August 11, 2026--Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, today announced a strategic partnership that gives life sciences researchers and data analysts secure, scalable access to high-quality, analysis-ready, real-world data in a protected environment, enabling faster, evidence-based decision-making.",
                "category": "company",
                "datetime": 1786447800,
                "headline": "Carelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences Researchers"
              },
              {
                "id": 141184788,
                "url": "https://finnhub.io/api/news?id=ae2bb843f1f9e99dca127f357933c6c758b8933eb937c5bfa96078361b9984de",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Los-Angeles---Jan-8-Mark-Cuban-At-The-Sp.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ELV",
                "summary": "Mark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.",
                "category": "company",
                "datetime": 1786422511,
                "headline": "Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 66,
            "discarded_article_count": 56
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 25.2,
        "grade": "優秀",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.1,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.1,
            "vcp_reason": "波幅收縮(11.5%→6.2%);站上MA50;升放量(近10日3日);Ready=N;Confirm=Y",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 945860,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 972810,
              "avg_vol_20": 909790,
              "avg_vol_30": 945860,
              "range_pct_10": 0.0618908133218704,
              "range_pct_20": 0.0737984089451576,
              "range_pct_30": 0.11497092440171597,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.028492588755207,
              "dist_to_20d_high": 0.0000959719644719712,
              "down_shrink_days": 2,
              "breakout_level_20d": 416.57999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.5383170888112531
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.5147644280317754,
              "turnoverUsdM": 791.46225798087,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.ELV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 395.59,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.8,
            "stop_loss_percent": 5,
            "take_profit_price": 454.1802,
            "target_multiplier": 2.2,
            "technical_strength": 2.45,
            "take_profit_percent": 9
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.7894320238663484,
          "stopLossPercent": 5.029528856063551,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.ELV",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 10.475,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.51
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 223.46
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1122
    },
    "kdj": {
      "d": 56.41,
      "j": 64.01,
      "k": 58.94,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 53.26
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 4139887,
      "recentSlope": 4198.7,
      "previousSlope": 184950
    },
    "rsi": 62.13,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 392.8013,
      "position": "SAR喺價下",
      "distancePct": 5.7,
      "previousTrend": "上升"
    },
    "ma50": 397.1982,
    "macd": {
      "macd": 3.752046131184329,
      "trend": "強烈看漲",
      "signal": 2.901565500073065,
      "histogram": 0.8504806311112643
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 6,
      "value": 402.3155,
      "position": "連續1-2日>VWAP",
      "consecutiveAbove": 1
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.97,
      "score": 6,
      "avgVolume": 965459,
      "currentVolume": 1900087
    },
    "derived": {
      "ma20": 400.949,
      "ma50": 397.1982,
      "prevClose": 396.9,
      "avgVolume10": 1094439,
      "avgVolume20": 965459,
      "changePercent": 4.95,
      "avgVolumeForScore": 965459
    },
    "ma_cross": {
      "ma20": 400.949,
      "ma50": 397.1982,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 400.079,
      "prevMa50": 396.602,
      "spreadPct": 0.94,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 388.2435,
      "upper": 413.6545,
      "position": "上半部"
    },
    "rsi_short": 63.7,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.97
    }
  }
}

Raw metrics JSON

{
  "close": 416.54,
  "volume": 1900087,
  "changePercent": 4.95
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.